Microbiology and Immunology · 2018 · 12 citations · 39 references
Life SciencesNeurobiologyNeuroscienceGene DeliveryMolecular NeuroscienceNeurodegenerationAlzheimer DiseaseAmyloid FormationNeurodegenerative DiseasesNeurodegenerative DisordersNeurological Gene TherapyProteolytic ProcessingAlzheimer Disease Gene TherapyAmyloid Beta PeptidesAmyloid Beta PlaquesAmyloid StructureNeurodegeneration PathogenesisNeurodegenerative Disease MechanismsProteolytic InactivationTransduction
Accumulation of amyloid β (Aβ40 and Aβ42) in the brain is a characteristic of Alzheimer's disease (AD). Because neprilysin (NEP) is a major Aβ-degrading enzyme, NEP delivery in the brain is a promising gene therapy for AD. Borna disease virus (BoDV) vector enables long-term transduction of foreign genes in the central nerve system. Here, we evaluated the proteolytic ability of NEP transduced by the BoDV vector and found that the amounts of Aβ40 and Aβ42 significantly decreased, which suggests that NEP expressed from the BoDV vector is functional to degrade Aβ.
39
Forecasting the global burden of Alzheimer's disease
Ron Brookmeyer, Elizabeth M. Johnson, Kathryn Ziegler‐Graham et al. · Alzheimer s & Dementia · 2007 · 3.4K citations
Medicine, Geriatric Medicine, Population Health Sciences +17
Candidate Gene for the Chromosome 1 Familial Alzheimer's Disease Locus
Ephrat Levy‐Lahad, Wilma Wasco, Parvoneh Poorkaj et al. · Science · 1995 · 2.6K citations
Lennart Mucke, Eliezer Masliah, Gui-Qiu Yu et al. · Journal of Neuroscience · 2000 · 1.9K citations · Full text